Table 1.
n | Median follow-up (months) | Relapse, n (%) | S45F mutation, n (%) | S45F as a risk factor | Ref. | |
Crude hazard ratio, HR (95% CI) | Adjusted hazard ratio (1), HR (95% CI) | |||||
89 | 62 | Not done | 19 (21.3) | 4.28 (1.75–10.48) | 4.28 (1.75–10.48) | [26] |
179 | 50 | 48 (26.8) | 39 (21.7) | Not done | 2.59 (1.19–5.65) | [27] |
101 | Not done | 50 (49.5) | 37 (36.6) | Not done | Not done | [28] |
95 | 31 | Not done | 23 (24.2) | Not done | Not done | [29] |
101 | 41 | 17 (16.8) | 18 (17.8) | 8.50 (1.85–39.00) | 6.20 (2.24–17.15) | [30] |